COVAXIN (BBV152) booster dose study shows Promising Results

COVAXIN (BBV152) booster dose study shows promising results. The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events.    6 months after receipt of

Read More

shugreek diabetes tablets-medifield

 

 

Jodarin-pain-cream

 

 

Magazines

SUBSCRIBE MAGAZINE

Click Here

error: Content is protected !!